Crown (NYSE:CCK) Given New $112.00 Price Target at UBS Group

Crown (NYSE:CCKFree Report) had its target price reduced by UBS Group from $120.00 to $112.00 in a research note issued to investors on Wednesday, MarketBeat.com reports. UBS Group currently has a neutral rating on the industrial products company’s stock.

A number of other equities research analysts have also issued reports on CCK. JPMorgan Chase & Co. lowered Crown from an “overweight” rating to a “neutral” rating and increased their target price for the company from $112.00 to $155.00 in a research note on Friday, February 6th. Bank of America lowered their target price on Crown from $131.00 to $126.00 and set a “buy” rating for the company in a research note on Monday, April 6th. Wolfe Research set a $115.00 target price on Crown in a research note on Friday, February 6th. Wall Street Zen lowered Crown from a “buy” rating to a “hold” rating in a research note on Saturday, April 18th. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of Crown in a research note on Friday, March 27th. Eleven investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, Crown has a consensus rating of “Moderate Buy” and an average price target of $120.93.

View Our Latest Analysis on CCK

Crown Price Performance

Shares of Crown stock opened at $99.09 on Wednesday. Crown has a twelve month low of $89.21 and a twelve month high of $116.62. The stock has a market capitalization of $11.12 billion, a P/E ratio of 15.78, a PEG ratio of 1.67 and a beta of 0.75. The company has a current ratio of 1.03, a quick ratio of 0.66 and a debt-to-equity ratio of 1.55. The business’s fifty day moving average price is $105.64 and its 200 day moving average price is $102.82.

Crown (NYSE:CCKGet Free Report) last issued its earnings results on Monday, April 27th. The industrial products company reported $1.86 earnings per share for the quarter, beating analysts’ consensus estimates of $1.75 by $0.11. Crown had a return on equity of 26.55% and a net margin of 5.65%.The firm had revenue of $3.26 billion for the quarter, compared to analysts’ expectations of $3.03 billion. During the same quarter last year, the firm earned $1.67 earnings per share. The firm’s revenue for the quarter was up 12.9% compared to the same quarter last year. Crown has set its FY 2026 guidance at 7.900-8.300 EPS and its Q2 2026 guidance at 2.100-2.200 EPS. As a group, research analysts anticipate that Crown will post 8.03 earnings per share for the current year.

Crown Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th were paid a $0.35 dividend. This represents a $1.40 annualized dividend and a dividend yield of 1.4%. This is a positive change from Crown’s previous quarterly dividend of $0.26. The ex-dividend date was Tuesday, March 17th. Crown’s payout ratio is presently 21.98%.

Insider Activity

In related news, CEO Timothy J. Donahue sold 7,500 shares of the business’s stock in a transaction dated Wednesday, April 15th. The stock was sold at an average price of $106.85, for a total value of $801,375.00. Following the transaction, the chief executive officer owned 451,070 shares in the company, valued at approximately $48,196,829.50. The trade was a 1.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Djalma Novaes, Jr. sold 29,734 shares of the business’s stock in a transaction dated Monday, February 23rd. The stock was sold at an average price of $114.80, for a total value of $3,413,463.20. Following the completion of the transaction, the chief operating officer owned 88,052 shares in the company, valued at approximately $10,108,369.60. This trade represents a 25.24% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 52,234 shares of company stock worth $5,832,363. Insiders own 0.90% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. Oregon Public Employees Retirement Fund lifted its stake in shares of Crown by 0.7% in the first quarter. Oregon Public Employees Retirement Fund now owns 22,972 shares of the industrial products company’s stock worth $2,303,000 after acquiring an additional 152 shares in the last quarter. Childress Capital Advisors LLC lifted its stake in shares of Crown by 11.7% in the first quarter. Childress Capital Advisors LLC now owns 8,735 shares of the industrial products company’s stock worth $876,000 after acquiring an additional 912 shares in the last quarter. R Squared Ltd lifted its stake in shares of Crown by 66.5% in the first quarter. R Squared Ltd now owns 6,755 shares of the industrial products company’s stock worth $677,000 after acquiring an additional 2,697 shares in the last quarter. Kathmere Capital Management LLC lifted its stake in shares of Crown by 52.6% in the first quarter. Kathmere Capital Management LLC now owns 3,207 shares of the industrial products company’s stock worth $322,000 after acquiring an additional 1,106 shares in the last quarter. Finally, Howe & Rusling Inc. lifted its stake in shares of Crown by 2.6% in the first quarter. Howe & Rusling Inc. now owns 103,048 shares of the industrial products company’s stock worth $10,331,000 after acquiring an additional 2,620 shares in the last quarter. Institutional investors and hedge funds own 90.93% of the company’s stock.

Crown News Summary

Here are the key news stories impacting Crown this week:

  • Positive Sentiment: Q1 beat and raised/affirmed outlook: Crown reported Q1 EPS $1.86 (vs. $1.75 est.) and revenue $3.26B (above estimates); revenue grew ~13% year/year and management set FY26 EPS guidance of $7.90–$8.30 and Q2 EPS of $2.10–$2.20 — supportive of longer‑term earnings visibility. Earnings Call Summary
  • Neutral Sentiment: Earnings call transcript published (useful for detail review of margin drivers, cost actions and regional trends). Earnings Call Transcript
  • Neutral Sentiment: Strategic expansion noted (India beverage-can capacity) and valuation commentary available for investors evaluating growth vs. capex. Valuation/Expansion Analysis
  • Negative Sentiment: Analyst price‑target cuts: JPMorgan trimmed its PT to $107 and moved to Neutral, and UBS cut its PT to $112 while keeping Neutral — these reductions temper sentiment despite remaining above the current price. JPMorgan PT Cut UBS PT Cut
  • Negative Sentiment: Margin pressure and tight can markets highlighted in recent coverage — analysts flag lower near‑term margins and input/market constraints that could compress profits even with sales growth. Deep Dive on Margins
  • Negative Sentiment: Headline: higher sales but lower profit in Q1 — upward revenue momentum offset by margin declines, which helps explain short‑term share pressure. Profit vs Sales Coverage

About Crown

(Get Free Report)

Crown Holdings, Inc is a leading global supplier of rigid packaging products for consumer goods markets. The company designs, manufactures and sells metal packaging for beverage, food, household, personal care and specialty products. Its portfolio includes aluminum and steel beverage cans, steel food cans, aluminum aerosols, metal closures and ends, offering customers end-to-end solutions from design and prototyping to large-scale production.

Founded in 1919 as the Crown Cork & Seal Company, Crown has grown through strategic acquisitions and investments in advanced manufacturing technologies.

See Also

Analyst Recommendations for Crown (NYSE:CCK)

Receive News & Ratings for Crown Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crown and related companies with MarketBeat.com's FREE daily email newsletter.